Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 32606565!7326345!32606565     free     free     free       Curr+Trends+Immunol 2020 ; 21 (ä): 17-23 Nephropedia Template TP {{tp|p=32606565|t=2020. Coronaviruses sugar shields as vaccine candidates |pdf=|usr=}}{{32606565}} gab.com Text Coronaviruses sugar shields as vaccine candidates JO: Curr Trends Immunol http://www.kidney.de/pget.php?&tw=1&pmid=32606565 #FOAvip A successful global healthcare response relies on versatile vaccines and production of broadly virus-neutralizing antibodies by the immune system to protect us from emerging infectious diseases. The present 2019 severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic highlights the urgent need for development of anti-viral biodefense. Due to the genetic and proteomic diversities of viral pathogens, establishing versatile anti-viral vaccines or therapeutic agents is highly challenging. Carbohydrate antigens represent an important class of immunological targets for vaccine development and immunotherapy against microbial infections. In this mini review, some concepts and strategies for exploring the potential of immunogenic sugar moieties as CoV vaccine candidates are presented. Twit Text FOAVip Coronaviruses sugar shields as vaccine candidates ????Curr Trends Immunol http://www.kidney.de/pget.php?&tw=1&pmid=32606565 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32606565 #FOAvip English Wikipedia <ref>{{Cite pmid|32606565}}</ref> Coronaviruses sugar shields as vaccine candidates #MMPMID32606565 Wang D Curr Trends Immunol 2020[]; 21 (ä): 17-23 PMID32606565show ga A successful global healthcare response relies on versatile vaccines and production of broadly virus-neutralizing antibodies by the immune system to protect us from emerging infectious diseases. The present 2019 severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic highlights the urgent need for development of anti-viral biodefense. Due to the genetic and proteomic diversities of viral pathogens, establishing versatile anti-viral vaccines or therapeutic agents is highly challenging. Carbohydrate antigens represent an important class of immunological targets for vaccine development and immunotherapy against microbial infections. In this mini review, some concepts and strategies for exploring the potential of immunogenic sugar moieties as CoV vaccine candidates are presented. äCoronaviruses sugar shields as vaccine candidates (epmc).pdf DeepDyve Pubget Overpricing